Enterprise League logo
Incyclix Bio Logo

Incyclix Bio

Durham, United States (US) · Health and Medical

Do your work at Incyclix Bio?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

May 2026

Overview

Incyclix Bio is a Durham, North Carolina-based biotechnology company pioneering precision oncology treatments.

We are dedicated to regaining cell cycle control in patients with advanced cancers by developing potent and selective cyclin-dependent kinase 2 (CDK2) inhibitors. Our scientific leadership focuses on understanding and targeting the aberrant proliferation driving various tumor types, including ovarian, breast, and lung cancers.

Founded by experts with a proven track record in CDK inhibitor discovery and development, Incyclix Bio leverages decades of combined experience to bring innovative therapies to patients in need. We are committed to advancing novel CDK inhibitors to address unmet medical needs and improve patient outcomes.

Incyclix Bio’s team has a history of successful drug development, originating from the foundation of G1 Therapeutics, where they pioneered the myelopreservation concept and successfully advanced trilaciclib to clinical trials.

Most teams do this before shortlisting


Contact Details

+1919-328-0003
info@incyclixbio.com

Durham, United States (US), 600 Park Office Dr

Founded

2020

Company Type

Private Limited Company

Employees

2-10

Keywords

You're invisible in searches for:

Add keywords that describe your company, services, or market to improve your visibility in search results.

Companies teams usually look at after Incyclix Bio

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.